FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Significant HCT/P Deviations at Cryos International

FDA warns Orlando, FL-based Cryos International about significant deviations from human cell, tissue, and cellular and tissue-based products regulatio...

latest-news-card-1
Human Drugs

Homeopathic Drug Products Enforcement Guide

FDA also says it expects that many homeopathic drug products will fall outside the categories of drug products that FDA intends to prioritize for enfo...

latest-news-card-1
Medical Devices

FDA Denies Petition on Scrubs as Medical Devices

FDA denies a petition filed by attorney James Czaban involving the regulation as medical devices of surgical scrubs for daily wear by healthcare worke...

latest-news-card-1
Human Drugs

PhRMA Issues with FDA Medical Queries

PhRMA urges FDA to work internationally to harmonize any change in the approach to premarket safety analytics.

latest-news-card-1
Medical Devices

Device Shortages Need More Transparency: FDA

CDRH researchers analyze the causes of medical device shortages before and during the pandemic and call for more information from manufacturers to mit...

latest-news-card-1

Coalition for Health AI Meeting Summary

The Coalition for Health AI releases a summary of stakeholder discussions on issues that could lead to guidance to enable trustworthy artificial intel...

latest-news-card-1
Biologics

FDA Defends Training/Support of Team Biologics

FDA defends criticism from three former FDA Team Biologics inspectors who left the agency over working conditions and complaints over lack of training...

latest-news-card-1
Human Drugs

AG Hair Limited CGMP Issues

FDA warns Coquitlam, Canada-based AG Hair Limited about CGMP violations in its production of hand sanitizer drugs for the U.S. market.

latest-news-card-1
Human Drugs

CGMP Violations at Glenmark Pharmaceuticals

FDA warns Glenmark Pharmaceuticals about CGMP violations in its production of finished drugs at a facility in Goa, India.

latest-news-card-1
Human Drugs

CGMP Violations in Kari Gran Inspection

FDA warns Seattle, WA-based Kari Gran, Inc., about CGMP violations and data integrity issues in its production of finished drugs.